Filtros de búsqueda

Lista de obras de Naureen Starling

3065 POSTER Safety and efficacy of sunitinib and FOLFIRI in combination in treatment-naive metastatic colorectal cancer (mCRC): a phase I study

artículo científico publicado en 2007

A case of Takotsubo syndrome following 5-fluorouracil chemotherapy

artículo científico publicado en 2014

A dose escalation study of gemcitabine plus oxaliplatin in combination with imatinib for gemcitabine-refractory advanced pancreatic adenocarcinoma.

artículo científico publicado en 2011

A phase I study of sunitinib in combination with FOLFIRI in patients with untreated metastatic colorectal cancer.

artículo científico publicado en 2011

A phase II study of antibody-drug conjugate, TAK-264 (MLN0264) in previously treated patients with advanced or metastatic pancreatic adenocarcinoma expressing guanylyl cyclase C.

artículo científico publicado en 2017

A phase II trial of preoperative chemotherapy with epirubicin, cisplatin and capecitabine for patients with localised gastro-oesophageal junctional adenocarcinoma

artículo científico publicado en 2009

Abstract 3589: Validation of the role of circulating tumor DNA (ctDNA) in tracking mechanisms of resistance to anti-EGFR monoclonal antibodies (AE-mABs): preliminary results of the PROSPECT-C prospective trial

artículo científico publicado en 2015

Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE study

artículo científico publicado en 2021

Adjuvant chemotherapy of colorectal cancer

artículo científico publicado en 2007

Attitudes of Patients With Gastrointestinal Cancers Toward Research Biopsies

artículo científico publicado en 2016

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

artículo científico publicado en 2008

Cetuximab in previously treated colorectal cancer.

artículo científico publicado en 2005

Circulating tumour DNA, a promising biomarker for the management of colorectal cancer

artículo científico publicado en 2017

Cisplatin Substitution with Carboplatin During Radical Chemoradiotherapy for Oesophagogastric Carcinoma: Outcomes from a Tertiary Centre

artículo científico publicado en 2018

Colorectal cancer

scholarly article

Colorectal cancer – Authors' reply

artículo científico publicado en 2010

Contemporary Tailored Oncology Treatment of Biliary Tract Cancers

artículo científico publicado en 2019

Current and Future Therapies for Advanced Gastric Cancer.

artículo científico publicado en 2015

Does shorter duration of chemotherapy worsen survival for elderly patients with colon cancer?

artículo científico publicado en 2007

Dose finding and early efficacy study of gemcitabine plus capecitabine in combination with bevacizumab plus erlotinib in advanced pancreatic cancer.

artículo científico publicado en 2009

Efficacy and toxicity of salvage weekly paclitaxel chemotherapy in non-Asian patients with advanced oesophagogastric adenocarcinoma

artículo científico publicado en 2016

Functional imaging and circulating biomarkers of response to regorafenib in treatment-refractory metastatic colorectal cancer patients in a prospective phase II study.

artículo científico

Gemcitabine based combination chemotherapy in advanced pancreatic cancer-indirect comparison

artículo científico publicado en 2008

Immunotherapy and pancreatic cancer: unique challenges and potential opportunities

artículo científico publicado en 2018

Impact of tumour histological subtype on chemotherapy outcome in advanced oesophageal cancer ⬇️

artículo científico publicado en 2017

Improved survival in resected oesophageal and gastric adenocarcinomas over a decade: the Royal Marsden experience 2001-2010.

artículo científico publicado en 2015

Intratumoral Transcriptome Heterogeneity Is Associated With Patient Prognosis and Sidedness in Patients With Colorectal Cancer Treated With Anti-EGFR Therapy From the CO.20 Trial

scientific article published on 29 September 2020

Investigating the feasibility of tumour molecular profiling in gastrointestinal malignancies in routine clinical practice

artículo científico publicado en 2018

Liposomal irinotecan in gemcitabine-refractory metastatic pancreatic cancer: efficacy, safety and place in therapy

artículo científico publicado en 2017

Longitudinal Liquid Biopsy and Mathematical Modeling of Clonal Evolution Forecast Time to Treatment Failure in the PROSPECT-C Phase II Colorectal Cancer Clinical Trial.

artículo científico publicado en 2018

MRI Tumor Regression Grade and Circulating Tumor DNA as Complementary Tools to Assess Response and Guide Therapy Adaptation in Rectal Cancer

scientific article published on 18 December 2019

Management of metastatic pancreatic cancer: Current treatment options and potential new therapeutic targets

artículo científico

Matuzumab plus epirubicin, cisplatin and capecitabine (ECX) compared with epirubicin, cisplatin and capecitabine alone as first-line treatment in patients with advanced oesophago-gastric cancer: a randomised, multicentre open-label phase II study.

artículo científico publicado en 2010

Meta-Analyses of Chemotherapy for Locally Advanced and Metastatic Pancreatic Cancer

artículo científico publicado en 2007

Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer: results of secondary end points analyses.

artículo científico publicado en 2008

Monoclonal antibodies against vascular endothelial growth factor and epidermal growth factor receptor in advanced colorectal cancers: present and future directions.

artículo científico publicado en 2004

Pancreatic neuroendocrine tumors: a review.

artículo científico publicado en 2015

Patient-derived organoids model treatment response of metastatic gastrointestinal cancers.

artículo científico publicado en 2018

Patients' willingness to participate in clinical trials and their views on aspects of cancer research: results of a prospective patient survey.

artículo científico publicado en 2016

Pharmacotherapy for oesophagogastric cancer.

scientific article published on January 2007

Phase I study of epirubicin, cisplatin and capecitabine plus matuzumab in previously untreated patients with advanced oesophagogastric cancer

artículo científico publicado en 2008

Platinum-Fluoropyrimidine and Paclitaxel-Based Chemotherapy in the Treatment of Advanced Anal Cancer Patients.

artículo científico publicado en 2017

Predictive molecular markers of response to epidermal growth factor receptor(EGFR) family-targeted therapies

artículo científico publicado en 2010

Prognostic factors and treatment outcomes in patients with Small Bowel Adenocarcinoma (SBA): the Royal Marsden Hospital (RMH) experience.

artículo científico publicado en 2015

Prognostic value of neutrophil-to-lymphocyte ratio in advanced oesophago-gastric cancer: exploratory analysis of the REAL-2 trial

artículo científico publicado en 2016

Role of erlotinib in the management of pancreatic cancer.

artículo científico publicado en 2006

Second-line therapy for advanced colorectal carcinoma.

artículo científico publicado en 2005

Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer

article

Survival Outcomes in Asymptomatic Patients With Normal Conventional Imaging but Raised Carcinoembryonic Antigen Levels in Colorectal Cancer Following Positron Emission Tomography-Computed Tomography Imaging.

artículo científico publicado en 2016

Survival from cancer of the pancreas in England and Wales up to 2001

artículo científico publicado en 2008

Survival in Advanced Esophagogastric Adenocarcinoma Improves With Use of Multiple Lines of Therapy: Results From an Analysis of More Than 500 Patients

artículo científico publicado en 2018

Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy.

artículo científico publicado en 2007

Targeting deficient DNA damage repair in gastric cancer.

artículo científico publicado en 2016

The Mutational Concordance of Fixed Formalin Paraffin Embedded and Fresh Frozen Gastro-Oesophageal Tumours Using Whole Exome Sequencing

artículo científico publicado en 2021

The combination of a chemotherapy doublet (gemcitabine and capecitabine) with a biological doublet (bevacizumab and erlotinib) in patients with advanced pancreatic adenocarcinoma. The results of a phase I/II study

The evolving immunotherapeutic landscape in advanced oesophagogastric cancer

artículo científico publicado en 2018

The genomic landscape of oesophagogastric junctional adenocarcinoma

artículo científico publicado en 2013

The value of day 8 blood count in treatment decisions when using oral vinorelbine in non-small cell lung cancer.

artículo científico publicado en 2010

Third line treatment of advanced oesophagogastric cancer: A critical review of current evidence and evolving trends

article

Thromboembolism in patients with advanced gastroesophageal cancer treated with anthracycline, platinum, and fluoropyrimidine combination chemotherapy: a report from the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Gr

artículo científico publicado en 2009

Trastuzumab beyond progression in HER2-positive advanced breast cancer: The Royal Marsden experience ⬇️

artículo científico publicado el 26 de abril de 2011

Trastuzumab in the management of gastroesophageal cancer: patient selection and perspectives

artículo científico publicado en 2016

Treatment and Survival Outcome of BRAF-Mutated Metastatic Colorectal Cancer: A Retrospective Matched Case-Control Study

artículo científico publicado en 2017

Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013.

artículo científico

Ultra-Sensitive Mutation Detection and Genome-Wide DNA Copy Number Reconstruction by Error-Corrected Circulating Tumor DNA Sequencing

artículo científico publicado en 2018

Ultra-sensitive mutation detection and genome-wide DNA copy number reconstruction by error corrected circulating tumour DNA sequencing

Up-to-Date Tailored Systemic Treatment in Pancreatic Ductal Adenocarcinoma

scientific article published on 05 September 2019

miR-21 expression and clinical outcome in locally advanced pancreatic cancer: exploratory analysis of the pancreatic cancer Erbitux, radiotherapy and UFT (PERU) trial

scientific article published on 05 February 2016

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda